NXSTAGE MEDICAL INC's ticker is NXTM and the CUSIP is 67072V103. A total of 175 filers reported holding NXSTAGE MEDICAL INC in Q3 2017. The put-call ratio across all filers is 0.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $3,598,000 | +2.6% | 125,700 | 0.0% | 0.04% | +30.0% |
Q3 2018 | $3,506,000 | -36.2% | 125,700 | -36.2% | 0.03% | -36.2% |
Q2 2018 | $5,496,000 | +12.2% | 197,000 | 0.0% | 0.05% | +2.2% |
Q1 2018 | $4,897,000 | +2.6% | 197,000 | 0.0% | 0.05% | +9.5% |
Q4 2017 | $4,773,000 | -5.0% | 197,000 | +8.2% | 0.04% | -10.6% |
Q3 2017 | $5,023,000 | – | 182,000 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ORACLE INVESTMENT MANAGEMENT INC | 2,721,906 | $73,029,000 | 11.38% |
DAFNA Capital Management LLC | 216,119 | $5,798,000 | 4.90% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,744,151 | $100,456,000 | 3.87% |
KOPP INVESTMENT ADVISORS LLC | 117,779 | $3,160,000 | 3.09% |
Perceptive Advisors | 1,818,189 | $48,782,000 | 2.78% |
Pennant Capital Management, LLC | 1,927,408 | $51,712,000 | 2.45% |
GILDER GAGNON HOWE & CO LLC | 4,955,630 | $132,960,000 | 2.24% |
PURA VIDA INVESTMENTS, LLC | 275,000 | $7,378,000 | 2.18% |
Portolan Capital Management | 545,032 | $14,623,000 | 1.90% |
Tamarack Advisers, LP | 110,000 | $2,951,000 | 1.84% |